indomethacin has been researched along with Bilirubinemia in 6 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome." | 4.80 | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. ( Strassburg, CP; Tukey, RH, 2000) |
| "The neurologic manifestations of neonatal hyperbilirubinemia in the central nervous system (CNS) exhibit high variations in the severity and appearance of motor, auditory and cognitive symptoms, which is suggestive of a still unexplained selective topography of bilirubin-induced damage." | 3.85 | Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment. ( Bottin, C; Dal Ben, M; Gazzin, S; Tiribelli, C; Zanconati, F, 2017) |
| "This report deals with three cases of Bartter's syndrome whose symptomatology was associated with indirect hyperbilirubinemia." | 1.28 | Bartter's syndrome associated with indirect hyperbilirubinemia: a possible clinical variety. ( Battisti, P; Cugini, P; Di Palma, L; Di Simone, S; Kawasaki, T; Sasaki, H; Uezono, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tukey, RH | 1 |
| Strassburg, CP | 1 |
| Dal Ben, M | 1 |
| Bottin, C | 1 |
| Zanconati, F | 1 |
| Tiribelli, C | 1 |
| Gazzin, S | 1 |
| Rheinlaender, C | 1 |
| Helfenstein, D | 1 |
| Walch, E | 1 |
| Berns, M | 1 |
| Obladen, M | 1 |
| Koehne, P | 1 |
| Hansen, TW | 1 |
| Bischof, P | 1 |
| Kaiser, H | 1 |
| Cugini, P | 1 |
| Sasaki, H | 1 |
| Kawasaki, T | 1 |
| Di Simone, S | 1 |
| Di Palma, L | 1 |
| Battisti, P | 1 |
| Uezono, K | 1 |
1 review available for indomethacin and Bilirubinemia
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; | 2000 |
5 other studies available for indomethacin and Bilirubinemia
| Article | Year |
|---|---|
Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment.
Topics: Animals; Bilirubin; Brain; Brain Diseases, Metabolic; Cell Survival; Curcumin; Encephalitis; Hyperbi | 2017 |
Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants.
Topics: Bilirubin; Child, Preschool; Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Female; Hemodynam | 2009 |
Ibuprofen for closure of patent ductus arteriosus: is it really safe in hyperbilirubinaemic infants?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Humans; Hyperbilirubinemia; Ibup | 2003 |
[Problems of rheumatism therapy in pregnant women].
Topics: Abortion, Spontaneous; Chloroquine; Female; Gold; Humans; Hyperbilirubinemia; Indomethacin; Penicill | 1978 |
Bartter's syndrome associated with indirect hyperbilirubinemia: a possible clinical variety.
Topics: Adult; Aldosterone; Bartter Syndrome; Chlorides; Female; Humans; Hydrocortisone; Hyperaldosteronism; | 1990 |